Dementia podcast

Dementia Researcher Cochrane Dementia and Cognitive Improvement Group | 7 June 2021 | Cochrane Dementia and Cognitive Improvement Group

Cochrane’s dementia podcast is produced in association with Alzheimer’s Research UK and Alzheimer’s Society. In this edition of the biweekly podcast Dr Anna Volkmer talks with the joint co-ordinating editors of the Cochrane Dementia Group. This bring together panels of early career researchers and other dementia experts to discuss their research and career topics to support other early career researchers. The podcast covers research investigating Alzheimer’s and other dementias, exploring prevention, diagnosis, treatments, care and how they’re working to better understand the disease and the brain.

The latest edition of the podcast is available on SoundCloud

See Cochrane for full details

More information about Cochrane Dementia and Cognitive Improvement

US approves first new Alzheimer’s drug in 20 years

via BBC News | US approves first new Alzheimer’s drug in 20 years

The first new treatment for Alzheimer’s disease for nearly 20 years has been approved by regulators in the United States, paving the way for its use in the UK.

Aducanumab targets the underlying cause of Alzheimer’s, the most common form of dementia, rather than its symptoms.

At least 100,000 people in the UK with a mild form of the disease could be suitable for the drug.

But approval from the UK regulator could take more than a year.

Charities have welcomed the news (Source: BBC News)

Full story from BBC News